Shandong Tumor Hospital

Jinan, Shandong 250117

0 studies enrolling now · 2 studies all time

What they study most

HER2-Positive Advanced Solid Tumor, HER2-Positive Salivary Gland Carcinomas, HER2-positive Biliary Tract Cancer, HER2-positive Breast Cancer, Small Cell Lung Cancer (SCLC)

Studies at this site

• Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer — Running, not enrolling
• Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors — Status unconfirmed